ClinVar Genomic variation as it relates to human health
NM_000019.4(ACAT1):c.890C>T (p.Thr297Met)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000019.4(ACAT1):c.890C>T (p.Thr297Met)
Variation ID: 279672 Accession: VCV000279672.23
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 11q22.3 11: 108142500 (GRCh38) [ NCBI UCSC ] 11: 108013227 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 6, 2016 Dec 22, 2024 Mar 11, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000019.4:c.890C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000010.1:p.Thr297Met missense NC_000011.10:g.108142500C>T NC_000011.9:g.108013227C>T NG_009888.2:g.30796C>T LRG_1400:g.30796C>T LRG_1400t1:c.890C>T LRG_1400p1:p.Thr297Met P24752:p.Thr297Met - Protein change
- T297M
- Other names
- -
- Canonical SPDI
- NC_000011.10:108142499:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00002
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
ACAT1 | - | - |
GRCh38 GRCh37 |
737 | 762 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Jul 1, 2022 | RCV000318454.12 | |
Pathogenic/Likely pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Mar 11, 2024 | RCV000844818.10 | |
ACAT1-related disorder
|
Likely pathogenic (1) |
no assertion criteria provided
|
Sep 13, 2024 | RCV003417871.5 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Sep 30, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000329051.6
First in ClinVar: Dec 06, 2016 Last updated: Dec 06, 2016 |
Comment:
The T297M missense change in the ACAT1 gene has been reported previously in association with beta-ketothiolase deficiency in an individual who presented with a severe … (more)
The T297M missense change in the ACAT1 gene has been reported previously in association with beta-ketothiolase deficiency in an individual who presented with a severe ketoacidotic attack who harbored another pathogenic missense variant on the opposite ACAT1 allele (in trans) (Fukao et al., 1995). In vivo expression studies found that T297M is associated with approximately 10% residual beta-ketothiolase enzyme activity (Fukao et al., 1995). The T297M variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The T297M variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. In summary we interpret T297M to be pathogenic. (less)
|
|
Likely pathogenic
(May 05, 2019)
|
criteria provided, single submitter
Method: research
|
Deficiency of acetyl-CoA acetyltransferase
Affected status: yes
Allele origin:
germline
|
Department of Pediatrics, Gifu University
Accession: SCV000966094.1
First in ClinVar: Aug 31, 2019 Last updated: Aug 31, 2019 |
Observation 1:
Number of individuals with the variant: 1
Number of families with the variant: 1
Clinical Features:
Ketoacidosis (present)
Family history: yes
Observation 2:
Method: Transient expression analysis of mutant cDNA
Result:
Reduced mitochondrial acetoacetyl-CoA thiolase enzyme activity and protein (10% that of wild type)
|
|
Likely pathogenic
(Aug 29, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Deficiency of acetyl-CoA acetyltransferase
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001366905.2
First in ClinVar: Jul 04, 2020 Last updated: Dec 12, 2020 |
Comment:
This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PP3.
|
|
Likely pathogenic
(Oct 27, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Deficiency of acetyl-CoA acetyltransferase
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV002600729.1
First in ClinVar: Nov 19, 2022 Last updated: Nov 19, 2022 |
Comment:
Variant summary: ACAT1 c.890C>T (p.Thr297Met) results in a non-conservative amino acid change located in the Thiolase, N-terminal domain (IPR020616) of the encoded protein sequence. Five … (more)
Variant summary: ACAT1 c.890C>T (p.Thr297Met) results in a non-conservative amino acid change located in the Thiolase, N-terminal domain (IPR020616) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251202 control chromosomes (gnomAD). c.890C>T has been reported in the literature in at least one compound heterozygous individual affected with Acetoacetyl-CoA Thiolase (T2) Deficiency (Wakazono_1995). These data do not allow any conclusion about variant significance. Wakazono_1995 also provided experimental evidence evaluating the variants impact on protein function, and reported that the variant has 10% residual activity. Four ClinVar submitters have assessed the variant since 2014: two classified the variant as likely pathogenic and two as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. (less)
|
|
Pathogenic
(Apr 06, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Deficiency of acetyl-CoA acetyltransferase
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002169976.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 14, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Thr297 amino acid residue in ACAT1. Other variant(s) that disrupt this … (more)
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Thr297 amino acid residue in ACAT1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28875337). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Studies have shown that this missense change alters ACAT1 gene expression (PMID: 7728148). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACAT1 protein function. ClinVar contains an entry for this variant (Variation ID: 279672). This missense change has been observed in individual(s) with mitochondrial acetoacetyl-CoA thiolase deficiency (PMID: 7728148). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 297 of the ACAT1 protein (p.Thr297Met). (less)
|
|
Likely pathogenic
(Mar 11, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Deficiency of acetyl-CoA acetyltransferase
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004214733.2
First in ClinVar: Dec 30, 2023 Last updated: Jun 17, 2024 |
|
|
Likely pathogenic
(Jul 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004131388.11
First in ClinVar: Nov 20, 2023 Last updated: Dec 22, 2024 |
Comment:
ACAT1: PM2, PM3, PM5, PP3
Number of individuals with the variant: 1
|
|
Likely pathogenic
(Sep 13, 2024)
|
no assertion criteria provided
Method: clinical testing
|
ACAT1-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004114807.2
First in ClinVar: Nov 20, 2023 Last updated: Oct 08, 2024 |
Comment:
The ACAT1 c.890C>T variant is predicted to result in the amino acid substitution p.Thr297Met. This variant has been reported in the compound heterozygous state in … (more)
The ACAT1 c.890C>T variant is predicted to result in the amino acid substitution p.Thr297Met. This variant has been reported in the compound heterozygous state in an individual with acetoacetyl-CoA thiolase deficiency (Fukao et al. 1995. PubMed ID: 7749408; Wakazono et al. 1995. PubMed ID: 7728148). Experimental studies suggest this variant impacts protein function (Fukao et al. 1995. PubMed ID: 7749408). A different amino acid substitution at this position (p.Thr297Lys) has been reported to be pathogenic (Su et al. 2017. PubMed ID: 28875337). This variant is reported in 0.0054% of alleles in individuals of East Asian descent in gnomAD. This variant is interpreted as likely pathogenic. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Mutation update on ACAT1 variants associated with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency. | Abdelkreem E | Human mutation | 2019 | PMID: 31268215 |
Clinical and molecular analysis of 6 Chinese patients with isoleucine metabolism defects: identification of 3 novel mutations in the HSD17B10 and ACAT1 gene. | Su L | Metabolic brain disease | 2017 | PMID: 28875337 |
Molecular, biochemical, and clinical characterization of mitochondrial acetoacetyl-coenzyme A thiolase deficiency in two further patients. | Wakazono A | Human mutation | 1995 | PMID: 7728148 |
Text-mined citations for rs886041122 ...
HelpRecord last updated Jan 13, 2025
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.